| |
 |
 Appeared in Latimes.
For more than a year now, California women have been able to get emergency
contraceptives without a prescription — in theory.
A state law allowing pharmacists to dispense the pills, which prevent
conception within 72 hours of unprotected intercourse, is aimed at
limiting unwanted pregnancies and, therefore, abortions. But some medical
groups, such as the California Medical Assn. and the American College of
Obstetricians and Gynecologists, say the law has created some barriers for
women seeking help. Many who need the drugs, they say, are unable to get
them.
Only 670 of the 5,200 or so pharmacies in the state have signed agreements
with physicians allowing them to dispense the drugs — a number the
California Pharmacists Assn. attributes to the newness of the law.
Furthermore, pharmacies that dispense the pills often add a $20 to $40
"consulting" fee to the drug, which retails for $25 to $30.
Pharmacists say the fees are justified because they're spending 15 to 20
minutes with each patient. But Joan Hall, a Sacramento lobbyist for the
gynecologists' group, says pharmacists don't charge such fees for other
drugs. "This is a highly discriminatory and predatory practice," she says.
"Women have to get these drugs in a certain amount of time, and these
prices act as barriers."
Those most affected by the fees are poor women who may not have a doctor
they can call for a prescription or a an insurer to pay the bill. Many
pharmacies say they don't charge consulting fees for women with
prescriptions.
But what most angers women's groups and medical organizations is a
one-page questionnaire that many pharmacists are requiring women to fill
out before they can buy the pills. The questionnaire is not required by
law, nor is it necessary to obtain traditional birth control pills. It
asks women details about their last menstrual period, whether they want
condoms or information about sexually transmitted infections, whether they
might have such an infection and whether they want a referral to a doctor.
The one-page list of 11 questions was created by an Oakland-based group
called Pharmacy Access Partnership along with state and national pharmacy
associations. The partnership is funded by several foundations that seek
to further access to contraceptives and give pharmacies a stronger role in
promoting community health. Its director, Jane Boggess, says that by
collecting the information, pharmacies will be able to make future
referrals for care.
Women's organizations, gynecologists' groups and the California Medical
Assn. say most of the questions are not relevant to whether women need
emergency contraceptives. "It was not the intent of the law to make
pharmacists into public health officials," says Shannon Smith-Crowley, a
lobbyist for the medical association. "What information do they really
need to gather?" Gynecologists say the pharmacists need to know only if a
woman has had unprotected sex in the last 72 hours and if she is allergic
to any medications.
The pharmacy association says the questionnaire is necessary to make sure
women are appropriate candidates for the drugs. Carlo Michelotti, chief
executive of the California Pharmacists Assn., defends the questionnaire,
saying pharmacists need information about patients since no prescription
is necessary and that they need to ensure that women know what they're
getting. He denies that it's intrusive, adding that the information is
confidential. "It's a huge turf issue," he says. "If pharmacists are doing
consulting without a doctor's intervention, they are treading on the turf
of nurses and physicians."
The fight has reached both the state and the federal levels. In the
California Legislature, Sen. Jackie Speier (D-Hillsborough) is sponsoring
a bill that would let pharmacists dispense emergency contraceptives
without taking special training, prohibit them from charging a
consultation fee, and limit dispensing fees to $3.55, the amount they can
charge to fill prescriptions for Medi-Cal patients. The bill does not
prohibit the questionnaire but states that pharmacists do not have a duty
to maintain special patient-medication records.
The Food and Drug Administration is expected to rule within the year on a
petition by the manufacturer of one of the drugs, Plan B, to make the drug
available over the counter. (The other drug is called Preven.)
The battle over fees and forms reflects the ongoing public struggle over
women's reproductive rights and who ultimately has control — the woman,
outside organizations or the marketplace. "It's about discrimination that
exists in reproductive health for women," Speier says.
Men don't fill out questionnaires or pay consulting fees to obtain Viagra.
Speier says there's a history of discrimination in California, from the
time contraceptives weren't covered by health maintenance organizations to
insurance surcharges for labor and delivery (the surcharges were outlawed
last year).
But it's also about money. Michelotti says druggists don't want the
Legislature telling them what they can charge and that if they can't
charge consulting fees, they simply won't sell the drugs.
If that happens, women's reproductive rights will be compromised yet
again.

May 19, 2003.
|
|